Breast Cancer Trial, Recruiting NCT04741737 Sponsor: Gangnam Severance Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT04741737
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 19 years old
  • People who have been diagnosed with breast cancer that has come back in the same breast (confirmed by tissue testing), and who are expected to have surgery for this
  • People whose original breast cancer surgery involved removing only part of the breast (partial mastectomy) and a sentinel lymph node biopsy (a procedure to check a small number of nearby lymph nodes)
  • People whose lymph nodes under the arm appear to be free of cancer based on current clinical assessment
  • People who understand the study and are willing to take part

Who may not be able to join:

  • People whose cancer has come back in lymph nodes in the armpit, above the collarbone, or near the breastbone, or in other nearby regions
  • People who are not considered suitable for a sentinel lymph node biopsy procedure (confirm with trial site)
  • People whose original breast cancer surgery involved full breast removal (mastectomy) or full removal of the lymph nodes under the arm
  • People whose cancer came back within one year of their original surgery
  • People who are already known to have cancer in their underarm lymph nodes, confirmed by tissue or cell testing, before the second surgery
  • People whose cancer has spread to other parts of the body beyond the breast area
  • People who have inflammatory breast cancer (a type of breast cancer that causes redness and swelling)
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joon Jeong, Gangnam Severance Hospital, Yonsei University College of Medicine

Phone: 82-2-2019-4401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gangnam Severance Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2020
Est. completion
31 January 2024

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

5 year disease free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov